Decreasing p53 overexpression in sequential, recurrent, oral squamous cell carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Abnormal p53 protein expression is a recognized indicator of malignancy, particularly in oral squamous cell carcinoma.
• p53 protein plays a crucial role in tumor suppression and is frequently altered in various cancers.

Purpose of the Study:

• To investigate the longitudinal changes in p53 protein expression in patients with multiple, recurrent oral squamous cell carcinomas.
• To explore the potential correlation between p53 expression levels and prognosis in these patients.

Main Methods:

• A longitudinal study analyzing fixed, paraffin-embedded tissue samples from 3 patients with multiple, recurrent squamous cell carcinomas of the floor of the mouth.
• Quantification of p53 protein expression in primary and subsequent recurrent tumors compared to normal tissue.

Main Results:

• All analyzed carcinomas exhibited increased p53 protein expression compared to normal tissues.
• A consistent reduction in p53 protein expression was observed from primary tumors to subsequent recurrent tumors across all 3 patients.
• Patients in this cohort have survived for at least 5 years, suggesting a potential favorable prognosis associated with reduced p53 expression in recurrences.

Conclusions:

• The reduction in p53 protein expression in sequential oral squamous cell carcinoma recurrences may be a marker for a favorable prognosis.
• Further large-scale studies are required to validate this preliminary observation and elucidate the underlying mechanisms.